AstraZeneca stock: Jefferies keeps GBP 175.00 target pre-market
Published on 10/21/2026 at 08:22 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst action and upcoming dates
- Jefferies maintained a Buy rating and a GBP 175.00 price target for AstraZeneca on October 20, 2026.
- AstraZeneca lists an ESMO management event for October 26, 2026.
- AstraZeneca stock trades pre-market at EUR 151.18 at 8:21 a.m. CEST at Lang & Schwarz on October 21, 2026.
On October 20, 2026, Jefferies maintained a Buy rating and a GBP 175.00 price target for AstraZeneca, according to a Markets Insider report citing TipRanks. AstraZeneca stock trades pre-market at EUR 151.18 at 8:21 a.m. CEST at Lang & Schwarz on October 21, 2026.
Jefferies maintains its rating
The report said Michael Leuchten of Jefferies kept the Buy rating and set the target at GBP 175.00. It also noted that AstraZeneca had received a Buy rating from Berenberg Bank on October 16, 2026, while Deutsche Bank maintained a Hold rating on October 14, 2026.
Ahead of the Xetra open
The pre-market indication is being monitored ahead of the Xetra session. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of AstraZeneca stock.
Business and the investor calendar
AstraZeneca describes itself on its investor-relations site as a worldwide pharmaceutical business. Its calendar lists an ESMO Meet the Management event for October 26, 2026, followed by the company’s 9M and Q3 2026 results on October 30, 2026. Market context: Market report FTSE 100.
